MedTrace Logo

Self-Powered Photodetectors for Smarter Healthcare

NCT06973317 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-07-10

No results posted yet for this study

Summary

The goal of this observational study is to evaluate the performance of a novel, non-invasive sensor device based on zirconium oxide photodetector designed to monitor key physiological parameters: blood glucose levels, heart rate, and blood oxygen saturation. The study focuses on adult hospital patients aged 18 to 75, of all sexes, who are undergoing routine monitoring and treatment unrelated to the investigational device.

The main questions this study aims to answer are:

To what extent do the signals obtained from the newly developed device correlate with standard hospital-based methods for measuring blood glucose, heart rate, and blood oxygen saturation?

Is the device feasible, safe, and accurate for use in a real-world clinical setting?

How stable and reproducible are the sensor signals across a demographically diverse patient population?

Can advanced data analysis methods, such as machine learning techniques, be used effectively to interpret the device's output and provide accurate estimates of glucose concentration?

What is the user perception of comfort, safety, and practicality when the device is used in a routine hospital environment?

This study will not assign any interventions to participants; it is purely observational. The novel device is non-invasive, and its use will not interfere with standard clinical care. Measurements will be taken passively or concurrently with routine care procedures.

Participants will:

Continue to receive standard clinical care, including conventional monitoring of glucose, heart rate, and oxygen saturation.

Undergo additional measurements using the investigational device, which will be placed non-invasively on the skin (finger).

Answer a short usability questionnaire assessing their experience with the device, including any discomfort, perceived safety, or ease of use.

Data obtained from the device will be compared with routine clinical data from standard hospital devices (e.g., glucometers, pulse oximeters) to evaluate accuracy and reliability. No pharmacological, radiological, or invasive procedures will be involved.

Conditions

  • Blood Glucose Monitoring

Sponsors & Collaborators

  • Wrocław University of Science and Technology

    lead OTHER

  • T. Marciniak Lower Silesian Specialist Hospital in Wrocław

    collaborator UNKNOWN

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2027-06-30
Primary Completion
2028-03-31
Completion
2028-12-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06973317 on ClinicalTrials.gov